Pharmaceutical Development of ATMPs

Oct 6th, 2019Oct 7th, 2019
London, 17
GB
https://management-forum.co.uk/product/details/2290/pharmaceutical-development-of-atmps?referrer=auntminnie
Phone:2077494730
This course will provide a comprehensive overview of the regulatory, quality, and GMP requirements to consider when developing ATMPs.
Latest in Home
2025 10 27 Evis Sala Thumb
The politics of health: Evis Sala takes first steps in Albania
October 27, 2025
Global Pharmaceutical Trade Network Adobe Tida
What’s the likely impact of €16B Hologic deal?
October 23, 2025
Join Us!
Sponsored
Join Us!
October 22, 2025
A 399 Fig 2 Pem Vs Cesm E Poster Eusobi 2025 Deabes Thumbnail
EUSOBI: Positron emission mammography demonstrates worth
October 22, 2025
More in Home
The politics of health: Evis Sala takes first steps in Albania
By Frances Rylands-Monk
Prof. Evis Sala has made a bold career move from head of radiology at a large hospital in Rome to Minister of Health in Albania. She talks exclusively to AuntMinnieEurope about her new challenge and the pivotal role of imaging in the nation’s EU roadmap.
October 27, 2025
2025 10 27 Evis Sala Thumb
What’s the likely impact of €16B Hologic deal?
By Erik L. Ridley and Philip Ward
Private equity firms are acquiring women’s health vendor Hologic. Senior industry experts reflect on the deal and the future consequences for the global women’s health sector.
October 23, 2025
Global Pharmaceutical Trade Network Adobe Tida
PET/MRI begins to deliver in breast cancer
By Philip Ward
The clinical role of PET/MRI is evolving rapidly in breast cancer, according to two studies presented at the European Society of Breast Imaging annual meeting.
October 23, 2025
Dedicated breast F-18 FDG PET/MRI exam pre- (A, D, G), mid- (B, E, H), and post-NAC (C, F, I) of a 41-year-old patient diagnosed with a triple negative (TN), grade 2, invasive carcinoma. The SUVmax values of the primary tumor were 14.68 pre-NAC, 1.69 mid-NAC, and 1.87 post-NAC, while SER values were 1.19, 0.52, and 0.63, respectively. Figure courtesy of Melissa Lenaerts, PhD, Dr. Thiemo van Nijnatten, PhD, et al and presented at EUSOBI 2025.
EUSOBI: Positron emission mammography demonstrates worth
By Edna Astbury-Ward, PhD
Positron emission mammography is proving useful in the presurgical assessment of invasive lobular carcinoma, researchers reported at the European Society of Breast Imaging (EUSOBI) annual meeting.
October 22, 2025
A 399 Fig 2 Pem Vs Cesm E Poster Eusobi 2025 Deabes Thumbnail
Amyloid PET can track patterns of neurodegeneration
By Maryam Payne
Early perfusion amyloid-PET shows potential for diagnosing and monitoring neurodegenerative disease and has possible advantages over FDG-PET scanning.
October 22, 2025
2025 10 20 Eanm Early Perfusion Imaging Fig1 Thumbnail
The epidemic of decision paralysis
By Dr. Paul McCoubrie
Decision-making is central to successful clinical practice, but no one seems to make decisions these days, writes Dr. Paul McCoubrie in the second part of his series about interactions between surgeons and radiologists.
October 21, 2025
Paul Mc Coubrie April 24
Global survey pinpoints key trends in spectral CT
By Liz Carey
The use of spectral CT is rising, but its clinical integration and quality assurance/quality control practices are inconsistent, the International Atomic Energy Agency has found.
October 20, 2025
Ct Scan Tech Adobe Stock By Peakstock g3ma9suare
Abnormal CT-FFR results translate to up to 7 years' cardiac risk
By Kate Madden Yee
The prognostic value of CT fractional flow reserve (CT-FFR) has been unclear, but the findings of a recent study from Denmark offer further insight.
October 20, 2025
Heart Damage
Transgender breast care emerges as priority for radiology
By Frances Rylands-Monk
Radiology needs to stop thinking of breast cancer as a disease that only concerns women and do much more to include transgender patients in breast care, says Dr. Anna D'Angelo from Rome.
October 20, 2025
Anna Portrait
Hot shots from Istanbul: Report from ESNR 2025
By Dr. Gennaro D'Anna
Radiologist Dr. Gennaro D'Anna provides a roundup and collection of images from the 48th annual meeting of the European Society of Neuroradiology (ESNR).
October 17, 2025
Istanbul Congress Center
PI-RADS v2.1 is 'highly sensitive' for prostate cancer detection on MRI
By Kate Madden Yee
PI-RADS v2.1 shows high sensitivity for categorizing clinically significant prostate cancer on MRI at both the patient and lesion levels, German researchers have found.
October 16, 2025
Benign Prostatic Hyperplasia
Breast CT gains clinical momentum in Europe
By Philip Ward
Dedicated contrast-enhanced breast CT is advancing as a clinical tool, but variations persist in acquisition protocols, particularly the timing of contrast administration. Dutch researchers have tried to resolve this issue.
October 16, 2025
Woman Lying On Ct Scanner Adobe Lasgkhidzetim
Page 1 of 61
Next Page